1. Home
  2. IMAX vs VERA Comparison

IMAX vs VERA Comparison

Compare IMAX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$39.06

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$31.86

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
VERA
Founded
1967
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
IMAX
VERA
Price
$39.06
$31.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
10
Target Price
$44.50
$81.30
AVG Volume (30 Days)
1.1M
1.0M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
0.07
N/A
Revenue
$410,212,000.00
N/A
Revenue This Year
$9.79
N/A
Revenue Next Year
$7.51
$472.48
P/E Ratio
$558.57
N/A
Revenue Growth
16.47
N/A
52 Week Low
$24.20
$19.07
52 Week High
$43.16
$56.05

Technical Indicators

Market Signals
Indicator
IMAX
VERA
Relative Strength Index (RSI) 56.09 38.63
Support Level $35.37 $27.19
Resistance Level $40.56 $31.92
Average True Range (ATR) 1.48 2.24
MACD 0.33 -0.16
Stochastic Oscillator 75.65 18.76

Price Performance

Historical Comparison
IMAX
VERA

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: